Catalyst
Slingshot members are tracking this event:
Phase 3 initiation of Aquinox Pharma's (AQXP) late-stage study of lead product candidate, AQX-1125, in BPS/IC expected in Q2 2016
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
AQXP |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 06, 2016
Occurred Source:
http://investor.aqxpharma.com/releasedetail.cfm?ReleaseID=987894
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Aqx-1125, Bps/ic, Ind, Q2 2016, Phase 3